282 related articles for article (PubMed ID: 32140653)
1. Hepatocellular Carcinoma-How to Determine Therapeutic Options.
Mehta N
Hepatol Commun; 2020 Mar; 4(3):342-354. PubMed ID: 32140653
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
3. Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.
Welling TH; Eddinger K; Carrier K; Zhu D; Kleaveland T; Moore DE; Schaubel DE; Abt PL
Liver Transpl; 2018 Sep; 24(9):1233-1242. PubMed ID: 29729113
[TBL] [Abstract][Full Text] [Related]
4. Medical Management of Hepatocellular Carcinoma.
Rich NE; Yopp AC; Singal AG
J Oncol Pract; 2017 Jun; 13(6):356-364. PubMed ID: 28605614
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma.
Rudnick SR; Russo MW
Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):265-275. PubMed ID: 29231769
[TBL] [Abstract][Full Text] [Related]
6. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma and Liver Transplantation: Changing Patterns and Practices.
Rich NE; Parikh ND; Singal AG
Curr Treat Options Gastroenterol; 2017 Jun; 15(2):296-304. PubMed ID: 28425018
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of Failures in Downstaging Treatment of Hepatocellular Carcinoma Prior to Liver Transplant-Preliminary Report on the Impact of Underestimations of Tumor Numbers and Tumor Sizes as Measured From Imaging Before Transplant.
Jeng KS; Huang CC; Lin CK; Lin CC; Huang CT; Chung CS; Weng MT; Chen KH
Transplant Proc; 2019 Jun; 51(5):1428-1434. PubMed ID: 31079940
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.
Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH
World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the treatment of hepatocellular carcinoma.
Padhya KT; Marrero JA; Singal AG
Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma treatment: hurdles, advances and prospects.
Kumari R; Sahu MK; Tripathy A; Uthansingh K; Behera M
Hepat Oncol; 2018 Apr; 5(2):HEP08. PubMed ID: 31293776
[TBL] [Abstract][Full Text] [Related]
12. Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience.
Abdelfattah MR; Al-Sebayel M; Broering D; Alsuhaibani H
Transplant Proc; 2015 Mar; 47(2):408-11. PubMed ID: 25769582
[TBL] [Abstract][Full Text] [Related]
13. Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field.
Doycheva I; Thuluvath PJ
J Clin Exp Hepatol; 2019; 9(5):588-596. PubMed ID: 31695249
[TBL] [Abstract][Full Text] [Related]
14. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.
Yao FY; Mehta N; Flemming J; Dodge J; Hameed B; Fix O; Hirose R; Fidelman N; Kerlan RK; Roberts JP
Hepatology; 2015 Jun; 61(6):1968-77. PubMed ID: 25689978
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: therapy and prevention.
Blum HE
World J Gastroenterol; 2005 Dec; 11(47):7391-400. PubMed ID: 16437707
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
17. Management of fibrolamellar hepatocellular carcinoma.
Chaudhari VA; Khobragade K; Bhandare M; Shrikhande SV
Chin Clin Oncol; 2018 Oct; 7(5):51. PubMed ID: 30395718
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategies for locally advanced hepatocellular carcinoma.
Fernandes ESM; Rodrigues PD; Álvares-da-Silva MR; Scaffaro LA; Farenzena M; Teixeira UF; Waechter FL
Transl Gastroenterol Hepatol; 2019; 4():12. PubMed ID: 30976715
[TBL] [Abstract][Full Text] [Related]
19. Goals and targets for personalized therapy for HCC.
Couri T; Pillai A
Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
[TBL] [Abstract][Full Text] [Related]
20. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
Yegin EG; Oymaci E; Karatay E; Coker A
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]